$65.73 $0.85 (1.3%)

04:00 PM EST on 11/21/19

Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Current Price $65.73 Mkt Cap $83.2B
Open $65.10 P/E Ratio 31.11
Prev. Close $64.88 Div. (Yield) $2.46 (3.7%)
Daily Range $64.51 - $65.80 Volume 5,361,430
52-Wk Range $60.89 - $70.50 Avg. Daily Vol. 6,060,142

Caps

How do you think NASDAQ:GILD will perform against the market?

Add Stock to CAPS Watchlist

All Players

3,453 Outperform
89 Underperform
 

All-Star Players

650 Outperform
14 Underperform
 

Wall Street

26 Outperform
3 Underperform
 

Top NASDAQ:GILD Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

blakeman1000 (44.14)
Submitted February 17, 2017

This company has proved that it can cure diseases. It has over $30B in cash. Good mgmt. Good yield. As of today at has a P/E of 7. If this company was not here tomorrow, people would notice.

nhatch3353 (53.22)
Submitted March 23, 2016

Patent problems and trouble with cancer drug trials.

Recent Community Commentary

Read the most recent pitches from players about GILD.

Recs

0
Member Avatar tester007 (< 20) Submitted: 4/8/2019 8:29:11 AM : Outperform Start Price: $65.95 NASDAQ:GILD Score: -8.06

just a year or so

Recs

0
Member Avatar elv1659 (< 20) Submitted: 4/2/2019 3:25:10 PM : Outperform Start Price: $65.18 NASDAQ:GILD Score: -7.64

This company is the leading cure hep c and will do well. Many people get hep c from needles and use of drugs and the demand for a cure is extreme.

Recs

0
Member Avatar TMFEBCapital (85.15) Submitted: 11/20/2018 11:14:15 AM : Outperform Start Price: $66.20 NASDAQ:GILD Score: -17.53

NASH data and filgotinib data in 2019 could finally mark the long-awaited turning point for this company. It's HCV drag should wane next year, allowing HIV sales growth and potentially, new drug approvals, to return it to top line growth in 2020.

Leaderboard

Find the members with the highest scoring picks in GILD.

Score Leader

BrianMotleyFool

BrianMotleyFool (64.82) Score: +536.73

The Score Leader is the player with the highest score across all their picks in GILD.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
UrineLuck73 < 20 1/29/2007 Outperform NS $13.94 +371.45% +131.66% +239.78 0 Comment
WilliamCrook2003 71.00 1/29/2007 1/25/2012 Outperform 5Y $13.94 +371.45% +131.66% +239.78 1 Comment
JSergeant 64.75 7/3/2006 Outperform 3Y $13.20 +397.83% +159.45% +238.38 0 Comment
predragj 47.30 1/30/2007 Outperform NS $14.12 +365.48% +131.40% +234.08 0 Comment
mxdfool < 20 12/15/2006 Outperform 5Y $14.19 +363.35% +130.60% +232.75 0 Comment
betsypurcell < 20 1/24/2007 Outperform NS $14.21 +362.71% +130.40% +232.31 0 Comment
opveiby 77.96 1/25/2007 Outperform 5Y $14.31 +359.24% +129.00% +230.24 0 Comment
Redskins2k9 < 20 1/25/2007 Outperform 5Y $14.31 +359.24% +129.00% +230.24 0 Comment
rmarinchek < 20 1/25/2007 Outperform 3W $14.31 +359.24% +129.00% +230.24 0 Comment
jer8899 68.65 1/23/2007 Outperform NS $14.28 +360.25% +130.43% +229.82 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GILD.